Clinical Trials Browser

Phase 3 × Neuroendocrine Tumors × Folfox protocol × Clear all

NCT04919226 2025-09-10

COMPOSE

Phase 3 Active not recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors